Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Nayax to Showcase New Digital Commerce Products for Specialty and Fashion Retail at NRF 2026
-
Rio Silver Highlights High-Grade Silver up to 6.26 g/t Au and 991 g/t Ag (28.9 oz per metric tonne) over 0.70 metres at Maria Norte and Advances a Clear Near-Term Development Path in Peru
-
Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair
-
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine’s Potential to Slow the Progression of Dementia with Lewy Bodies
-
Silexion Therapeutics Releases CEO Letter to Shareholders Highlighting 2025’s Significant Achievements and Outlining Upcoming Milestones for 2026
-
SL Green and Rockpoint Announce Joint Venture for Ownership of 100 Park Avenue
-
PMGC Holdings Inc. Announces Strategic Share Acquisition in Micro Modular Reactor (MMR) Focused Nuclear Energy Company, Nuclea Energy Inc.
-
Centerra Gold Provides Notice of Fourth Quarter 2025 Results and Conference Call
-
Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates v
-
Enable Injections Announces $30 Million Investment from Sanofi to Accelerate Manufacturing Capabilities
-
Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program
-
Atsena Therapeutics Appoints McDavid Stilwell as Chief Financial Officer
-
Edible Garden Preliminary Holiday Sales Surge 26.4% Year-Over-Year During Key Time Period
-
BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer
-
Habit Brings Back Gotta Habit Meal Deals
-
Bread Financial Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call for Jan. 29
-
Reporting dates in 2026
-
Silexion Therapeutics Releases CEO Letter to Shareholders Highlighting 2025’s Significant Achievements and Outlining Upcoming Milestones for 2026
-
Biocon Biologics to Expand Biosimilar Oncology Portfolio, Outline Strategic Vision at the 2026 J.P. Morgan Healthcare Conference
-
Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)
-
Alvotech announces planned CEO succession and leadership transition
-
Mark Your Calendar: Hong Kong to Host Asia’s 50 Best Restaurants 2026 after Historic Double Win
-
Dimensional Fund Advisors Ltd. : Form 8.3 - AUCTION TECHNOLOGY GROUP - Ordinary Shares
-
Cartesian Therapeutics Announces New Employment Inducement Grants
-
Riverside Insights and Prometric Join Forces to Deliver Gold-Standard Assessments to International Markets
-
Papa Johns and the CHL® Launch “Champions of Tomorrow” to Support Canada’s Young Hockey Players
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Atea Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Kymera Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13
-
Crown Crafts to Participate in the ICR Conference
-
Funnel’s 2025: A year of validation + execution
-
Alesta to Highlight ALE1 Clinical Progress at 44th Annual JP Morgan Healthcare Conference
-
Tonix Pharmaceuticals to Present at Two Investor Conferences in January 2026
-
Plug to Participate in Goldman Sachs Energy, CleanTech & Utilities Conference
-
Evotrex Debuts the Evotrex-PG5: The World’s First Power-Generating RV Trailer Built for Elevated Off-Grid Travel
-
Aurora Mobile's GPTBots.ai Partners with Echosens China to Improve Efficiency and Service Quality in Non-Invasive Liver Diagnostics
-
Anfield Energy Achieves Transformative Milestones in 2025, Positioning Itself as a Key Player in America’s Nuclear Renaissance
-
Fischer Imaging to Present at RESI JPM 2026 Innovator’s Pitch Challenge
-
Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy
-
NovaBridge Presents Positive Givastomig Dose Expansion Data from the Phase 1b Combination Study in Patients with 1L Metastatic Gastric Cancer
-
P10 Opens New Office in Dubai, Strengthening Capabilities in the Middle East Region
-
Lantronix Redefines Integrated Edge Intelligence With AI-Powered Surveillance Ecosystem and Real-Time Video Analytics
-
EVTV Executes Transformational AZIO AI Acquisition Framework at $3.00 Per Share
-
LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture
-
Instil Bio’s Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco
-
Boralex Commissions Sanjgon Energy Storage Project, Initially Tilbury, Its First Operational Storage Facility in North America
-
BioCryst to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Key Mining Corp., a Global Critical Minerals and Infrastructure Company, and Compass Digital Acquisition Corp. Announce Definitive Merger Agreement
